nefazodone has been researched along with Day Blindness in 6 studies
nefazodone: may be useful as an opiate adjunct
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Luu, C | 1 |
| Kiely, P | 1 |
| Crewther, D | 1 |
| Kowal, L | 1 |
| Crewther, S | 1 |
| Hundal, KS | 1 |
| Chen, S | 1 |
| Moore, W | 1 |
| Tranos, P | 1 |
| Joshi, N | 1 |
| Schwartz, K | 1 |
| Greenberg, WM | 1 |
| Shuster, J | 1 |
| Mosberian, P | 1 |
| Leung, M | 1 |
| Hollander, Y | 1 |
| Remick, RA | 1 |
6 other studies available for nefazodone and Day Blindness
| Article | Year |
|---|---|
Central and peripheral vision loss associated with nefazodone usage.
Topics: Adult; Antidepressive Agents, Second-Generation; Color Perception; Electroretinography; Evoked Poten | 2003 |
Dyskinetopsia during light adaptation associated with nefazodone treatment.
Topics: Adaptation, Ocular; Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Ma | 2003 |
Nefazodone and visual side effects.
Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Middle Aged; Piperazi | 1997 |
Visual field "shimmering" associated with nefazodone.
Topics: Bupropion; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Male; Middle Aged; P | 1999 |
Nefazodone and visual disturbances.
Topics: Antidepressive Agents, Second-Generation; Drug Monitoring; Humans; Male; Middle Aged; Patient Educat | 1999 |
Nefazodone-induced visual disturbances.
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Humans; Male; Piperazines; Triazo | 1999 |